SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing ...
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...
Morning Overview on MSN
A dust-sized device could supercharge quantum computers
A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...
A device smaller than a grain of dust may help unlock the kind of quantum computers people have only dreamed about. Built on ...
Impressively, the unit registered the lowest frequency loss of any chip to date. Specifically, the engineers noted that the new chip was 15x more stable and 100x more efficient in terms of microwave ...
CMOS-built optical phase modulators shrink laser control hardware and power use for trapped atom quantum computers, enabling larger stable qubit arrays at work. (Nanowerk News) Researchers have made a ...
Abstract: This letter introduces a three-phase multilevel converter for the integration of multiple battery submodules. The circuit comprises a synergetic modulated quasi-single stage design that ...
Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CAS Complex modulation of optical fields (i.e., the control of light’s amplitude and phase) is vital to the ...
Demonstrated strong safety and favorable pharmacokinetics in Phase 1 study A First-in-class oral small molecule modulating immune cell metabolism via glycogen phosphorylase inhibition Once-daily oral ...
“We’re highly encouraged by the safety profile observed in our Phase 2a study and the notable impact of our oral Nck modulator AX-158 on key disease biomarkers and clinical severity scores,” said Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results